2017 Q2 Form 10-K Financial Statement

#000164033417002176 Filed on October 13, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 2016 Q2
Revenue $0.00 $995.00 $0.00
YoY Change -83.64%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $220.0K $500.0K $100.0K
YoY Change 120.0% 648.86% -83.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $43.60K $10.00K
YoY Change 0.0% -35.23% -83.33%
% of Gross Profit
Operating Expenses $230.0K $546.8K $110.0K
YoY Change 109.09% -72.97% -81.97%
Operating Profit -$545.8K -$110.0K
YoY Change -72.94% -81.97%
Interest Expense -$140.0K $46.05K -$400.0K
YoY Change -65.0% -84.23% 300.0%
% of Operating Profit
Other Income/Expense, Net -$154.5K
YoY Change -83.3%
Pretax Income -$370.0K -$700.0K -$510.0K
YoY Change -27.45% -76.19% -28.17%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$370.0K -$700.3K -$510.0K
YoY Change -27.45% -76.2% -28.17%
Net Earnings / Revenue -70384.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 -$0.30 -$0.71
COMMON SHARES
Basic Shares Outstanding 464.7M shares 319.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.00K $40.00K $10.00K
YoY Change 300.0% 300.0%
Cash & Equivalents $42.57K $40.00K $14.64K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses $4.167K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $42.57K $40.00K $18.80K
YoY Change 126.37% 100.0% -98.75%
LONG-TERM ASSETS
Property, Plant & Equipment $39.04K $40.00K $82.64K
YoY Change -52.76% -50.0% 7.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $39.04K $40.00K $82.64K
YoY Change -52.76% -50.0% 7.93%
TOTAL ASSETS
Total Short-Term Assets $42.57K $40.00K $18.80K
Total Long-Term Assets $39.04K $40.00K $82.64K
Total Assets $81.61K $80.00K $101.4K
YoY Change -19.55% -20.0% -93.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.993K $10.00K $4.643K
YoY Change 29.08% 8.56%
Accrued Expenses $0.00 $130.0K $30.00K
YoY Change -100.0% 333.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $170.0K $170.0K $0.00
YoY Change -100.0%
Total Short-Term Liabilities $496.8K $500.0K $38.55K
YoY Change 1188.8% 1150.0% -83.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $496.8K $500.0K $38.55K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $496.8K $500.0K $38.55K
YoY Change 1188.8% 1150.0% -83.71%
SHAREHOLDERS EQUITY
Retained Earnings -$4.783M -$4.083M
YoY Change 17.15% 258.05%
Common Stock $52.00K $46.47K
YoY Change 11.9% 1127.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$415.2K -$420.0K $62.90K
YoY Change
Total Liabilities & Shareholders Equity $81.61K $80.00K $101.4K
YoY Change -19.55% -20.0% -93.56%

Cashflow Statement

Concept 2017 Q2 2017 2016 Q2
OPERATING ACTIVITIES
Net Income -$370.0K -$700.3K -$510.0K
YoY Change -27.45% -76.2% -28.17%
Depreciation, Depletion And Amortization $10.00K $43.60K $10.00K
YoY Change 0.0% -35.23% -83.33%
Cash From Operating Activities -$80.00K -$270.7K -$10.00K
YoY Change 700.0% 238.35% -87.5%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0K $298.6K 20.00K
YoY Change 400.0% 171.46% -75.0%
NET CHANGE
Cash From Operating Activities -80.00K -$270.7K -10.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 100.0K $298.6K 20.00K
Net Change In Cash 20.00K $27.93K 10.00K
YoY Change 100.0% -244.72%
FREE CASH FLOW
Cash From Operating Activities -$80.00K -$270.7K -$10.00K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$80.00K -$270.7K -$10.00K
YoY Change 700.0% 170.68% -87.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001568969
CY2017 dei Trading Symbol
TradingSymbol
apyp
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
725104637 shares
CY2016Q4 dei Entity Public Float
EntityPublicFloat
1100000 usd
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
265 usd
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14637 usd
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4167 usd
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2016Q2 us-gaap Assets Current
AssetsCurrent
18804 usd
CY2017Q2 us-gaap Assets Current
AssetsCurrent
42567 usd
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82644 usd
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39044 usd
CY2016Q2 us-gaap Assets
Assets
101448 usd
CY2017Q2 us-gaap Assets
Assets
81611 usd
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4643 usd
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5993 usd
CY2016Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
32000 usd
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
128000 usd
CY2016Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
454 usd
CY2017Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
174904 usd
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
73608 usd
CY2016Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1452 usd
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
114316 usd
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
38549 usd
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
496821 usd
CY2016Q2 us-gaap Liabilities
Liabilities
38549 usd
CY2017Q2 us-gaap Liabilities
Liabilities
496821 usd
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
46466 usd
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
51997 usd
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4098473 usd
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4210156 usd
CY2017Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
105000 usd
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4082540 usd
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4782863 usd
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
1338971 usd
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
62899 usd
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-415210 usd
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101448 usd
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81611 usd
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175226 usd
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218826 usd
CY2016Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
87240 usd
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
464667527 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519973313 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
464667527 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
519973313 shares
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6083 usd
CY2017 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
995 usd
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6126 usd
CY2016 us-gaap Professional Fees
ProfessionalFees
1885063 usd
CY2017 us-gaap Professional Fees
ProfessionalFees
365103 usd
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60642 usd
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138087 usd
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3913 usd
CY2016 us-gaap Depreciation
Depreciation
67315 usd
CY2017 us-gaap Depreciation
Depreciation
43600 usd
CY2016 us-gaap Operating Expenses
OperatingExpenses
2023059 usd
CY2017 us-gaap Operating Expenses
OperatingExpenses
546790 usd
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-2016976 usd
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-545795 usd
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-633293 usd
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-108478 usd
CY2016 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
292049 usd
CY2017 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
46050 usd
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-925342 usd
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-154528 usd
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-2942318 usd
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-700323 usd
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142317965 shares
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
470400985 shares
CY2017 apyp Stock Payable For Service
StockPayableForService
105000 usd
CY2016 apyp Stock Issued During Period Value Common Stock Issued For Deferred Financing Cost
StockIssuedDuringPeriodValueCommonStockIssuedForDeferredFinancingCost
3850 usd
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
337500 usd
CY2016 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
1324896 usd
CY2017 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
117214 usd
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
337500 usd
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2017 apyp Issuance Of Convertible Notes For Services
IssuanceOfConvertibleNotesForServices
25000 usd
CY2016 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
1494483 usd
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
22702 usd
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
248218 usd
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
27760 usd
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-339 usd
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
167 usd
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4167 usd
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
366 usd
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1350 usd
CY2016 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
32000 usd
CY2017 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
96000 usd
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21130 usd
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18290 usd
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-81226 usd
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-270678 usd
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
700 usd
CY2016 us-gaap Payments For Software
PaymentsForSoftware
20000 usd
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19300 usd
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
usd
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
133750 usd
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
225000 usd
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
18852 usd
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
98517 usd
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
24909 usd
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
114898 usd
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
298608 usd
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14372 usd
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27930 usd
CY2016 us-gaap Interest Paid
InterestPaid
usd
CY2017 us-gaap Interest Paid
InterestPaid
usd
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2016 apyp Purchase Of Mobile Application Software For Convertible Loan
PurchaseOfMobileApplicationSoftwareForConvertibleLoan
58000 usd
CY2016 us-gaap Stock Issued1
StockIssued1
3850 usd
CY2016 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
342530 usd
CY2017 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
31600 usd
CY2016 us-gaap Notes Reduction
NotesReduction
982366 usd
CY2017 us-gaap Notes Reduction
NotesReduction
85614 usd
CY2016 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
191750 usd
CY2017 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
90000 usd
CY2016 apyp Cancelation Of Issuance Of Common Stock For Services
CancelationOfIssuanceOfCommonStockForServices
172 usd
CY2017 apyp Common Stock Payable For Services
CommonStockPayableForServices
105000 usd
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On June 9, 2017, the Company entered into a Management Services Agreement (&#8220;MSA&#8221;) with The Diagnostic Group, LLC, A Delaware limited liability company (&#8220;TDG&#8221;) under the terms of which, the Company shall perform activities related to direct marketing of TDG products and services to healthcare providers. The initial term of the Agreement will be for thirty-six (36) months from the effective date. The MSA shall automatically renew for successive one (1) year terms, unless either Party gives the other Party ninety (90) days&#8217; written notice of termination prior to the effective date of any renewal term, or unless the MSA is terminated earlier in accordance with Section 6 of the MSA. The Company will be paid for providing services to directly recruited customers at the rate of 35% of the Net Collected Revenue collected from non-federally funded payors by third party providers affiliated or contracted with TDG for ancillary services ordered by recruited customers less any lab specific costs related to any referred samples and/or services and less any refunds or chargebacks. The Company will be paid by the 15th of each month for Net Collected Revenue from the previous month.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</p>
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
three-month terms, which shall be automatically extended for successive three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term
CY2017Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2017 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock
CY2017 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
175131324 shares
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
69284 usd
CY2016 apyp Number Of Common Stock Issued For Conversion Of Debt And Accrued Interest
NumberOfCommonStockIssuedForConversionOfDebtAndAccruedInterest
420743693 shares
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Use of Estimates and Assumptions</i></p><p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p>
CY2013Q1 us-gaap Lessor Leasing Arrangements Operating Leases Term Of Contract
LessorLeasingArrangementsOperatingLeasesTermOfContract
P3M
CY2016 us-gaap Advertising Expense
AdvertisingExpense
6126 usd
CY2017 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2017Q2 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-454254 usd
CY2016 apyp Otc Markets Annual Fee
OtcMarketsAnnualFee
4167 usd
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2016 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
78000 usd
CY2016 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
4613 usd
CY2017Q2 us-gaap Notes Payable Current
NotesPayableCurrent
250877 usd
CY2016Q2 us-gaap Interest Payable Current
InterestPayableCurrent
454 usd
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11267 usd
CY2016Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
usd
CY2017Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
87240 usd
CY2016Q2 us-gaap Convertible Debt
ConvertibleDebt
454 usd
CY2017Q2 us-gaap Convertible Debt
ConvertibleDebt
174904 usd
CY2016Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2017Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2017Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
37000 usd
CY2017 apyp Number Of Lender For Notes Payable Principal Assignment
NumberOfLenderForNotesPayablePrincipalAssignment
2 lender
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
pure
CY2017 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
pure
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2496 usd
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2426 usd
CY2017 apyp Number Of Common Stock Issued For Conversion Of Debt And Accrued Interest
NumberOfCommonStockIssuedForConversionOfDebtAndAccruedInterest
55305786 shares
CY2017 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2016 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
72142 usd
CY2017 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
160587 usd
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-72142 usd
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-160587 usd
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
176347 usd
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
336934 usd
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
176347 usd
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
336934 usd
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
962669 usd
CY2017 apyp Stock Issued During Period Shares Issued For Stock Payable
StockIssuedDuringPeriodSharesIssuedForStockPayable
30000000 shares
CY2017Q2 apyp Percentage Net Collected Revenue Paid To Recruited Customers
PercentageNetCollectedRevenuePaidToRecruitedCustomers
0.35 pure
CY2016 apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
133750 usd
CY2017 apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
225000 usd

Files In Submission

Name View Source Status
0001640334-17-002176-index-headers.html Edgar Link pending
0001640334-17-002176-index.html Edgar Link pending
0001640334-17-002176.txt Edgar Link pending
0001640334-17-002176-xbrl.zip Edgar Link pending
appyea_10k.htm Edgar Link pending
appyea_ex311.htm Edgar Link pending
appyea_ex321.htm Edgar Link pending
apyp-20170630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
apyp-20170630_def.xml Edgar Link unprocessable
apyp-20170630_lab.xml Edgar Link unprocessable
apyp-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20170630.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20170630_cal.xml Edgar Link unprocessable